Data gathered: June 23
Alternative Data for ORIC Pharmaceuticals
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 3 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 12,000 | Sign up | Sign up | Sign up |
| Google Trends | 7 | Sign up | Sign up | Sign up |
| Patents | 39 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 688 | Sign up | Sign up | Sign up |
| Twitter Followers | 483 | Sign up | Sign up | Sign up |
| Twitter Mentions | N/A | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 132 | Sign up | Sign up | Sign up |
About ORIC Pharmaceuticals
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States.
| Price | $10.00 |
| Target Price | Sign up |
| Volume | 808,830 |
| Market Cap | $793M |
| Year Range | $4.26 - $12.54 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
All You Need to Know About Oric Pharmaceuticals (ORIC) Rating Upgrade to BuyJune 19 - Yahoo |
|
Does Oric Pharmaceuticals (ORIC) Have the Potential to Rally 104.99% as Wall Street Analysts Expect?June 18 - Yahoo |
 |
ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap Down After Insider SellingJune 13 - ETF Daily News |
|
What Makes Oric Pharmaceuticals, Inc. (ORIC) a Strong Momentum Stock: Buy Now?June 13 - Yahoo |
|
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Raises Stock Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC)June 13 - ETF Daily News |
|
Cantor Fitzgerald Predicts ORIC FY2026 EarningsJune 13 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 0 | 0 | 0 | -30M | -33M | -0.420 |
| Q4 '24 | 530,000 | 0 | 530,000 | -36M | -39M | -0.510 |
| Q3 '24 | 0 | 0 | 0 | -35M | -38M | -0.490 |
| Q2 '24 | 0 | 270,000 | -270,000 | -32M | -36M | -0.450 |
| Q1 '24 | 0 | 260,000 | -260,000 | -25M | -29M | -0.370 |
Insider Transactions View All
| Piscitelli Dominic filed to sell 101,817 shares at $10. June 13 '25 |
| Piscitelli Dominic filed to sell 103,817 shares at $10. June 11 '25 |
| Piscitelli Dominic filed to sell 102,117 shares at $10. June 11 '25 |
| Piscitelli Dominic filed to sell 105,093 shares at $10. June 11 '25 |
| Piscitelli Dominic filed to sell 103,864 shares at $10. June 9 '25 |
Similar companies
Read more about ORIC Pharmaceuticals (ORIC) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, google trends, patents, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews & linkedin employees.
What is the Market Cap of ORIC Pharmaceuticals?
The Market Cap of ORIC Pharmaceuticals is $793M.
What is the current stock price of ORIC Pharmaceuticals?
Currently, the price of one share of ORIC Pharmaceuticals stock is $10.00.
How can I analyze the ORIC stock price chart for investment decisions?
The ORIC stock price chart above provides a comprehensive visual representation of ORIC Pharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling ORIC Pharmaceuticals shares. Our platform offers an up-to-date ORIC stock price chart, along with technical data analysis and alternative data insights.
Does ORIC offer dividends to its shareholders?
As of our latest update, ORIC Pharmaceuticals (ORIC) does not offer dividends to its shareholders. Investors interested in ORIC Pharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of ORIC Pharmaceuticals?
Some of the similar stocks of ORIC Pharmaceuticals are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.